GNH USA

Europe — EMA

Levetiracetam Krka

GNH USA supplies Levetiracetam Krka (Levetiracetam), an anticonvulsant for partial, myoclonic and generalized tonic‑clonic seizures.

Levetiracetam

Request sourcing

1
Pack/s

What is Levetiracetam?

Levetiracetam, the active ingredient in Levetiracetam Krka, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed to control various seizure types in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Levetiracetam used for?

Levetiracetam is an antiepileptic drug used to manage seizure disorders across several clinical presentations.

Partial-onset seizures: reduces the frequency and severity of focal seizures. Myoclonic seizures: diminishes rapid, involuntary muscle jerks. Generalized tonic‑clonic seizures: helps prevent loss of consciousness and convulsive episodes.

What are the side effects of Levetiracetam?

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness - Fatigue - Headache - Nausea

Serious or Rare Side Effects: - Severe skin reactions such as Stevens‑Johnson syndrome - Mood or behavioral changes, including depression or suicidal thoughts - Blood disorders like neutropenia or thrombocytopenia

What precautions apply to Levetiracetam?

When prescribing levetiracetam, clinicians should consider several safety measures. - Renal function monitoring: adjust dose in patients with impaired clearance. - Psychiatric assessment: watch for mood alterations or suicidal ideation. - Discontinuation guidance: avoid abrupt cessation to prevent seizure rebound. - Pregnancy considerations: use only if benefits outweigh potential risks. - Store at room temperature: keep in the original pack, protect from moisture.

What does Levetiracetam interact with?

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenytoin: can reduce levetiracetam exposure. - Phenobarbital: may decrease drug concentration. - Rifampin: induces metabolism, lowering efficacy.

Moderate Interactions (Monitor Closely): - Valproic acid: potential increase in levetiracetam levels. - Central nervous system depressants: additive sedation risk. - Alcohol: may enhance central nervous system effects.

Frequently asked questions

What conditions is Levetiracetam Krka used to treat?+
Levetiracetam Krka is prescribed for the management of partial‑onset seizures, myoclonic seizures, and generalized tonic‑clonic seizures in patients with epilepsy. It helps reduce the frequency and intensity of these seizure types, contributing to overall seizure control.
How does levetiracetam work to control seizures?+
Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This interaction stabilises neuronal membranes and diminishes abnormal electrical activity, thereby lowering the likelihood of seizure initiation and spread.
What is the usual dose of Levetiracetam Krka?+
The dosage of Levetiracetam Krka is individualized by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Healthcare professionals determine the appropriate dose and titration schedule for each patient.
Is Levetiracetam Krka safe during pregnancy or breastfeeding?+
Levetiracetam is classified as Pregnancy Category B, indicating that animal studies have not shown risk, but there are limited human data. It may be used during pregnancy only if the potential benefit justifies the potential risk. Breastfeeding decisions should be made in consultation with a healthcare provider.
How do I order Levetiracetam Krka from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Levetiracetam compare with other antiepileptic drugs?+
Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancing agents such as valproate. It generally has a favourable interaction profile and is well tolerated, but individual response and side‑effect patterns vary, so clinicians choose therapy based on patient‑specific factors.
What are the recommended storage conditions for Levetiracetam Krka?+
Levetiracetam Krka should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.
How is Levetiracetam Krka administered?+
Levetiracetam Krka is taken orally, usually as a tablet, with or without food. The exact administration schedule—once daily, twice daily, or more frequent—depends on the prescriber’s dosing plan and the patient’s therapeutic needs.
What are the most serious risks associated with Levetiracetam Krka?+
Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, significant mood or behavioural changes (including depression or suicidal thoughts), and hematologic abnormalities like neutropenia or thrombocytopenia. Patients should be monitored closely for these events and seek immediate medical attention if they occur.
Who should not use Levetiracetam Krka?+
Levetiracetam is contraindicated in patients with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for individuals with severe renal impairment who have not had dose adjustments, and for pregnant or breastfeeding women unless the benefits outweigh potential risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Levetiracetam
Route
Oral Use
Manufacturer
Krka, D.D., Novo Mesto
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU